,8 NSCLC is further classified based on the presence of actionable genetic alterations, which influence tumor growth and invasiveness, with some alterations (eg, EGFR and ALK) conferring a better prognosis.9 The gene discussed is ALK; the disease is non-small cell lung carcinoma.